Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


WHO’s Expanded Essential Drugs List Includes High-Priced Anticancers & Immunomodulators

Executive Summary

The World Health Organization has published its latest list of essential medicines, with a number of expensive drugs for cancers and autoimmune disorders figuring for the first time. The organization says that all patients should have access to life-saving medicines regardless of their ability to pay, but the pharmaceutical industry says this should be done with caution to avoid undermining innovation.


Related Content

Ambitious WHO Plan To Help 50 Nations Improve Regulatory Capacity


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts